Seelos Therapeutics Stock Return On Asset
Seelos Therapeutics fundamentals help investors to digest information that contributes to Seelos Therapeutics' financial success or failures. It also enables traders to predict the movement of Seelos OTC Stock. The fundamental analysis module provides a way to measure Seelos Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seelos Therapeutics otc stock.
Seelos |
Seelos Therapeutics OTC Stock Return On Asset Analysis
Seelos Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Seelos Therapeutics Return On Asset | -2.61 |
Most of Seelos Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seelos Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Seelos Therapeutics has a Return On Asset of -2.6111. This is 70.16% lower than that of the Pharmaceuticals sector and 88.94% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Seelos Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Seelos Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Seelos Therapeutics could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics of similar companies.Seelos Therapeutics is currently under evaluation in return on asset category among its peers.
Seelos Fundamentals
Return On Equity | -5.84 | |||
Return On Asset | -2.61 | |||
Profit Margin | 2.03 % | |||
Operating Margin | (8.35) % | |||
Current Valuation | 10.45 M | |||
Shares Outstanding | 581 K | |||
Shares Owned By Insiders | 0.49 % | |||
Shares Owned By Institutions | 4.46 % | |||
Number Of Shares Shorted | 170.89 K | |||
Price To Book | 15.10 X | |||
Price To Sales | 0.37 X | |||
Revenue | 2.2 M | |||
Gross Profit | (46.65 M) | |||
EBITDA | (40.44 M) | |||
Net Income | (37.88 M) | |||
Cash And Equivalents | 41.25 M | |||
Cash Per Share | 0.39 X | |||
Total Debt | 14.23 M | |||
Debt To Equity | 0.73 % | |||
Current Ratio | 3.60 X | |||
Book Value Per Share | (135.50) X | |||
Cash Flow From Operations | (23.91 M) | |||
Short Ratio | 0.14 X | |||
Earnings Per Share | 351.04 X | |||
Target Price | 120.0 | |||
Beta | 1.85 | |||
Market Capitalization | 743.68 K | |||
Total Asset | 5.42 M | |||
Retained Earnings | (252.63 M) | |||
Working Capital | (33.52 M) | |||
Net Asset | 5.42 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income. Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Seelos OTC Stock
If you are still planning to invest in Seelos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seelos Therapeutics' history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |